Dr. Albert Hwa is a graduate of Cornell University, where he earned a degree in Chemical Engineering. Dr. Hwa received his PhD in Biological Engineering at Massachusetts Institute of Technology. He is the Operations Director for Joslin's Center for Cell-Based Therapy for Diabetes (CCTD) and a Lecturer at Harvard Medical School. At CCTD, Dr. Hwa works with investigators at Joslin and other collaborating institutions to identify technologies ripe for translation and establish the research programs to bring them to clinical testing. Stem cell-derived beta cells are the primary target for the center for its central role in correcting insulin insufficiency in diabetes.